User 172200

Merck, Schering-Plough: Confessions of a Vytorin Patient

Still ANOTHER interesting article - AJC :june 15.'07:1706-1713 - "In conclusion, the lipid modulating and anti-inflammatory effects of ezetimibe/simvastatin provide ADDITIONAL benefits NOT realized by statin monotherapy alone" As far as "proof" that Vytorin lessons the incidence of heart attacks & strokes: I feel it could be reasonably assumed from the literature, that a medication both having the statin anti-inflammatory AND LDH lowering effects should be cardiovascular protective (like the different brands of aspirin) No doubt follow up research will substantiate this point. Disclosure I am an MD with NO relevant pharma holdings.